Hers vs MangoRx: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
MangoRx beats Hers overall, scoring 7.5/10 vs 7.3/10. MangoRx is more affordable at $299/mo vs $348/mo. Choose Hers for women who want glp-1 access from a well-known, publicly trad. Choose MangoRx for users who want a multi-service telehealth platform covering .
A side-by-side comparison of Hers and MangoRx covering pricing, scores, medication types, insurance, and more to help you decide.
Hers
#33 of 40The women's health arm of Hims & Hers Health (NYSE: HIMS), offering compounded GLP-1 medications with a polished app experience designed for women's health needs.
Visit HersMangoRx
#23 of 40Multi-service telehealth platform offering compounded GLP-1 alongside other health services.
Visit MangoRx| Feature | Hers | MangoRx |
|---|---|---|
| Our Score | 7.3/10 | 7.5/10 |
| Starting Price | $348/mo | $299/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Women who want GLP-1 access from a well-known, publicly traded telehealth brand | Users who want a multi-service telehealth platform covering weight loss and men's health |
| Ranking | #33 | #23 |
Pros & Cons Compared
Hers
Pros
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Women-focused branding, content, and support — not a men's health platform with a women's tab
- +$199/mo all-inclusive for compounded semaglutide with consultations and free shipping
- +Broader women's health platform — can address hormonal, skin, and wellness needs alongside weight loss
Cons
- −Pivoted away from some compounded formulations after FDA crackdown — medication availability can shift
- −Compounded only — no brand-name Wegovy or Zepbound through the platform
- −Generic support experience — large patient volume means less personalized attention
- −Higher price than competitors like TrimRx ($179) or Enhance MD ($115) for a similar compounded product
MangoRx
Pros
- +Oral dissolving tablets exclusively — zero injections for any GLP-1 option
- +Publicly traded on NASDAQ (MGRX) — SEC-required financial transparency that private competitors can't match
- +Semaglutide tablet includes Vitamin B6 to help reduce nausea during treatment
- +Free 100% online consultation with no video call required
Cons
- −$299/mo for oral semaglutide is 2-3x the cost of injectable alternatives at $99-149/mo
- −Early-stage public company with limited revenue — stock performance reflects financial uncertainty
- −Only oral tablet format available — no injectable options if you want higher bioavailability
Our Verdict
MangoRx edges out Hers with a score of 7.5/10 vs 7.3/10. If budget is your priority, MangoRx starts at $299/mo compared to Hers's $348/mo. Choose Hers if you want: women who want glp-1 access from a well-known, publicly traded telehealth brand. Choose MangoRx if you want: users who want a multi-service telehealth platform covering weight loss and men's health.